COMPLETE SKIN CLEARANCE IS NOT ATTAINED BY MOST PATIENTS RECEIVING BIOLOGICS FOR MODERATE TO SEVERE PLAQUE PSORIASIS: INTERIM RESULTS OF AN INTERNATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0
|
作者：
Augustin, M. [1 ]
Lacour, J. [2 ]
Reich, K. [3 ]
Horne, L. [4 ]
Williams, A. [4 ]
Horton, J. [5 ]
Slynn, G. [6 ]
Hammond, E. R. [4 ]
机构：
[1] Univ Med Ctr Hamburg, Hamburg, Germany
[2] Hop Archet, Nice, France
[3] Dermatologikum Hamburg, Hamburg, Germany
[4] AstraZeneca, Gaithersburg, MD USA
[5] Clin Solut Grp, Raleigh, NC USA
[6] AstraZeneca, Alderley Pk, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1321
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY7
引用
下载
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [21] Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study
    Elnabawi, Youssef A.
    Dey, Amit K.
    Goyal, Aditya
    Groenendyk, Jacob W.
    Chung, Jonathan H.
    Belur, Agastya D.
    Rodante, Justin
    Harrington, Charlotte L.
    Teague, Heather L.
    Baumer, Yvonne
    Keel, Andrew
    Playford, Martin P.
    Sandfort, Veit
    Chen, Marcus Y.
    Lockshin, Benjamin
    Gelfand, Joel M.
    Bluemke, David A.
    Mehta, Nehal N.
    CARDIOVASCULAR RESEARCH, 2019, 115 (04) : 721 - 728
  • [22] Biologics Initiation in Moderate vs Severe Rheumatoid Arthritis Patients: Prospective Observational Study from a Canadian Registry
    Guo, Nancy
    Li, Xiuying
    Movahedi, Mohammad
    Cesta, Angela
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1685 - 1686
  • [23] Biologics Initiation in Moderate Vs Severe Rheumatoid Arthritis Patients: Prospective Observational Study From a Canadian Registry
    Guo, Nancy
    Movahedi, Mohammad
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 832 - 832
  • [24] BIOLOGICS INITIATION IN MODERATE VS SEVERE RHEUMATOID ARTHRITIS PATIENTS: PROSPECTIVE OBSERVATIONAL STUDY FROM A CANADIAN REGISTRY
    Guo, N.
    Li, X.
    Movahedi, M.
    Cesta, A.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 454 - 455
  • [25] Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study
    Rigopoulos, Dimitrios
    Angelakopoulos, Charalampos
    Apalla, Zoi
    Georgiou, Sophia
    Delli, Florentina
    Drosos, Alexandros
    Zafiriou, Efterpi
    Katsantonis, John
    Lazaridou, Elisavet
    Panagakis, Pantelis
    Papadavid, Evangelia
    Papakonstantis, Markos
    Roussaki-Schulze, Angeliki-Viktoria
    Sotiriou, Elena
    Anastasiadis, Georgios
    Tampouratzi, Eleftheria
    Chasapi, Vasiliki
    Sfaelos, Konstantinos
    Ioannides, Dimitrios
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [26] Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
    Jerry Bagel
    John Nia
    Peter W. Hashim
    Manmath Patekar
    Ana de Vera
    Sophie Hugot
    Kuan Sheng
    Summer Xia
    Isabelle Gilloteau
    Elisa Muscianisi
    Andrew Blauvelt
    Mark Lebwohl
    Dermatology and Therapy, 2018, 8 : 571 - 579
  • [27] Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
    Bagel, Jerry
    Nia, John
    Hashim, Peter W.
    Patekar, Manmath
    de Vera, Ana
    Hugot, Sophie
    Sheng, Kuan
    Xia, Summer
    Gilloteau, Isabelle
    Muscianisi, Elisa
    Blauvelt, Andrew
    Lebwohl, Mark
    DERMATOLOGY AND THERAPY, 2018, 8 (04) : 571 - 579
  • [28] Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
    Pinter, Andreas
    Eyerich, Kilian
    Costanzo, Antonio
    Garrelts, Alyssa
    Schuster, Christopher
    Mert, Can
    Lampropoulou, Anastasia
    Fotiou, Konstantinos
    Maul, Julia-Tatjana
    Papp, Kim A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [29] HIGHER LEVELS OF SKIN CLEARANCE ARE ASSOCIATED WITH DECREASED INDIRECT COSTS RELATED TO PRODUCTIVITY LOSS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Apol, E.
    Merrall, E. L.
    VALUE IN HEALTH, 2018, 21 : S450 - S451
  • [30] Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis: results of a prospective longitudinal pilot study
    Boehncke, Sandra
    Salgo, Rebekka
    Garbaraviciene, Jurate
    Beschmann, Heike
    Ackermann, Hanns
    Ochsendorf, Falk Ruediger
    Boehncke, Wolf-Henning
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S36 - S36
12345